• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血后的医学并发症。

Medical complications after subarachnoid hemorrhage.

机构信息

Department of Neurology, Neurologic Intensive Care Unit, Martin-Luther University, Halle-Wittenberg, Leipzig, Germany.

出版信息

Neurosurg Clin N Am. 2010 Apr;21(2):325-38. doi: 10.1016/j.nec.2009.10.012.

DOI:10.1016/j.nec.2009.10.012
PMID:20380973
Abstract

The prevention and management of medical complications are important for improving outcomes after subarachnoid hemorrhage (SAH). Fever, anemia requiring transfusion, hyperglycemia, hyponatremia, pneumonia, hypertension, and neurogenic cardiopulmonary dysfunction occur frequently after SAH. There is increasing evidence that acute hypoxia and extremes of blood pressure can exacerbate brain injury during the acute phase of bleeding. There are promising strategies to minimize these complications. Randomized controlled trials are needed to evaluate the risks and benefits of these and other medical management strategies after SAH.

摘要

预防和处理医学并发症对于改善蛛网膜下腔出血(SAH)后的预后非常重要。SAH 后常发生发热、需要输血的贫血、高血糖、低钠血症、肺炎、高血压和神经源性心肺功能障碍。越来越多的证据表明,急性缺氧和血压极端变化会加重出血急性期的脑损伤。有一些很有前途的策略可以最大程度地减少这些并发症。需要进行随机对照试验来评估这些和其他 SAH 后医学管理策略的风险和获益。

相似文献

1
Medical complications after subarachnoid hemorrhage.蛛网膜下腔出血后的医学并发症。
Neurosurg Clin N Am. 2010 Apr;21(2):325-38. doi: 10.1016/j.nec.2009.10.012.
2
Medical complications after subarachnoid hemorrhage: new strategies for prevention and management.蛛网膜下腔出血后的医学并发症:预防与管理的新策略
Curr Opin Crit Care. 2006 Apr;12(2):78-84. doi: 10.1097/01.ccx.0000216571.80944.65.
3
The three tenors of subarachnoid hemorrhage: fever, anemia, and hyperglycemia.
Crit Care Med. 2006 Mar;34(3):897-8. doi: 10.1097/01.CCM.0000202431.87062.98.
4
The systemic implications of aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血的全身影响。
J Neurol Sci. 2007 Oct 15;261(1-2):143-56. doi: 10.1016/j.jns.2007.04.047. Epub 2007 Jun 4.
5
[Aneurysmal subarachnoid hemorrhage - therapy and complications].[动脉瘤性蛛网膜下腔出血——治疗与并发症]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2010 Jan;45(1):8-17. doi: 10.1055/s-0029-1243372. Epub 2010 Jan 20.
6
Impact of medical complications on outcome after subarachnoid hemorrhage.医学并发症对蛛网膜下腔出血后预后的影响。
Crit Care Med. 2006 Mar;34(3):617-23; quiz 624. doi: 10.1097/01.ccm.0000201903.46435.35.
7
Anemia and transfusion after aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血后的贫血与输血。
J Neurosurg Anesthesiol. 2013 Jan;25(1):66-74. doi: 10.1097/ANA.0b013e31826cfc1d.
8
Fever after subarachnoid hemorrhage: risk factors and impact on outcome.蛛网膜下腔出血后的发热:危险因素及其对预后的影响。
Neurology. 2007 Mar 27;68(13):1013-9. doi: 10.1212/01.wnl.0000258543.45879.f5. Epub 2007 Feb 21.
9
Cardiac manifestations of subarachnoid hemorrhage.蛛网膜下腔出血的心脏表现。
Expert Rev Cardiovasc Ther. 2011 Mar;9(3):303-7. doi: 10.1586/erc.10.189.
10
Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage.动脉瘤性蛛网膜下腔出血患者贫血及输血相关并发症
Crit Care Med. 2008 Jul;36(7):2070-5. doi: 10.1097/CCM.0b013e31817c1095.

引用本文的文献

1
Awake prone positioning in a patient with respiratory impairment due to subarachnoid hemorrhage: a case report.蛛网膜下腔出血所致呼吸功能障碍患者的清醒俯卧位:一例报告
J Med Case Rep. 2025 May 28;19(1):255. doi: 10.1186/s13256-025-05311-1.
2
Diffuse microglial responses and persistent EEG changes correlate with poor neurological outcome in a model of subarachnoid hemorrhage.在蛛网膜下腔出血模型中,弥漫性小胶质细胞反应和持续性脑电图变化与不良神经学预后相关。
Sci Rep. 2024 Jun 13;14(1):13618. doi: 10.1038/s41598-024-64631-2.
3
Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance.
增强的肾清除率会影响伴有和不伴有增强的肾清除率的创伤性脑损伤患者的左乙拉西坦浓度。
BMC Neurol. 2024 Jan 2;24(1):12. doi: 10.1186/s12883-023-03515-w.
4
Animal Welfare Aspects in Planning and Conducting Experiments on Rodent Models of Subarachnoid Hemorrhage.在蛛网膜下腔出血啮齿动物模型实验的规划和实施中考虑动物福利问题。
Cell Mol Neurobiol. 2023 Nov;43(8):3965-3981. doi: 10.1007/s10571-023-01418-5. Epub 2023 Oct 20.
5
Early management of patients with aneurysmal subarachnoid hemorrhage in a hospital with neurosurgical/neuroendovascular facilities: a consensus and clinical recommendations of the Italian Society of Anesthesia and Intensive Care (SIAARTI)-part 2.在具备神经外科/神经血管内治疗设施的医院中对动脉瘤性蛛网膜下腔出血患者的早期管理:意大利麻醉与重症监护学会(SIAARTI)的共识与临床建议 - 第2部分
J Anesth Analg Crit Care. 2022 May 19;2(1):21. doi: 10.1186/s44158-022-00049-4.
6
Neurological Pupil Index and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: A Retrospective Multicentric Study.神经瞳孔指数与蛛网膜下腔出血后迟发性脑缺血:一项回顾性多中心研究。
Neurocrit Care. 2023 Aug;39(1):116-124. doi: 10.1007/s12028-023-01744-y. Epub 2023 May 24.
7
Clustering of serum biomarkers involved in post-aneurysmal subarachnoid hemorrhage (aSAH) complications.与颅内动脉瘤性蛛网膜下腔出血(aSAH)后并发症相关的血清生物标志物聚类。
Neurosurg Rev. 2023 Mar 3;46(1):63. doi: 10.1007/s10143-023-01967-9.
8
The value of comorbidities and illness severity scores as prognostic tools for early outcome estimation in patients with aneurysmal subarachnoid hemorrhage.合并症和疾病严重程度评分作为预测工具对动脉瘤性蛛网膜下腔出血患者早期预后的评估价值。
Neurosurg Rev. 2022 Dec;45(6):3829-3838. doi: 10.1007/s10143-022-01890-5. Epub 2022 Nov 11.
9
Impact of Anemia Severity on the Outcome of an Aneurysmal Subarachnoid Hemorrhage.贫血严重程度对动脉瘤性蛛网膜下腔出血预后的影响
J Clin Med. 2022 Oct 24;11(21):6258. doi: 10.3390/jcm11216258.
10
Neurogenic pulmonary edema in subarachnoid hemorrhage: relevant clinical concepts.蛛网膜下腔出血中的神经源性肺水肿:相关临床概念
Egypt J Neurosurg. 2021;36(1):27. doi: 10.1186/s41984-021-00124-y. Epub 2021 Nov 15.